Paper39576992
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.
Zhu W and 24 others. Blood, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19. Papers, record 39576992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39576992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Spike Glycoprotein, Coronavirus | Major topic |
| SARS-CoV-2 | Major topic |
| Antibodies, Viral | Major topic |
| Autoantibodies | Major topic |
| Humans | |
| Immunoglobulin G | |
| Male | |
| Female | |
| Platelet Activation | |
| Middle Aged | |
| Platelet Factor 4 | |
| Aged | |
| Protein Domains | |
| Heparin | |
| Blood Platelets | |
| Thrombocytopenia | |
| Adult | |
| P-Selectin |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL167668 | NHLBI NIH HHS | United States | P01HL167668 | PubMed and NIH | NIH RePORTER |
| R01 HL161127 | NHLBI NIH HHS | United States | R01HL161127 | PubMed and NIH | NIH RePORTER |
| R01 HL148120 | NHLBI NIH HHS | United States | R01HL148120 | PubMed and NIH | NIH RePORTER |
| R56 AI159536 | NIAID NIH HHS | United States | R56AI159536 | PubMed and NIH | NIH RePORTER |
| R01 HL158932 | NHLBI NIH HHS | United States | R01HL158932 | PubMed and NIH | NIH RePORTER |
| P01 HL044612 | NHLBI NIH HHS | United States | P01HL044612 | PubMed and NIH | NIH RePORTER |
| UL1 TR001436 | NCATS NIH HHS | United States | UL1TR001436 | PubMed and NIH | NIH RePORTER |
| T32 GM080202 | NIGMS NIH HHS | United States | T32GM080202 | PubMed and NIH | NIH RePORTER |
| R01 AI079087 | NIAID NIH HHS | United States | R01AI079087 | PubMed and NIH | NIH RePORTER |
| R01 HL130724 | NHLBI NIH HHS | United States | R01HL130724 | PubMed and NIH | NIH RePORTER |
| OT2 HL156812 | NHLBI NIH HHS | United States | OT2HL156812 | PubMed and NIH | NIH RePORTER |
| R01 HL175474 | NHLBI NIH HHS | United States | R01HL175474 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 39913341 | Antibodies to PF4 in severe COVID-19: same but different. | https://conductscience.org/library/papers/39913341 |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15738055 | Defective B cell tolerance checkpoints in systemic lupus erythematosus. | J Exp Med | 2005 | https://conductscience.org/library/papers/15738055 | PubMed |
| 2 | 33397677 | Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33397677 | PubMed |
| 3 | 14699083 | Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. | J Exp Med | 2004 | https://conductscience.org/library/papers/14699083 | PubMed |
| 4 | 34413139 | Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34413139 | PubMed |
| 5 | 32091533 | Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. | JAMA | 2020 | https://conductscience.org/library/papers/32091533 | PubMed |
| 6 | 33123171 | Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD). | Front Immunol | 2020 | https://conductscience.org/library/papers/33123171 | PubMed |
| 7 | 32555388 | Convergent antibody responses to SARS-CoV-2 in convalescent individuals. | Nature | 2020 | https://conductscience.org/library/papers/32555388 | PubMed |
| 8 | 27096317 | Recognition of Endogenous Nucleic Acids by the Innate Immune System. | Immunity | 2016 | https://conductscience.org/library/papers/27096317 | PubMed |
| 9 | 34010947 | Diverse functional autoantibodies in patients with COVID-19. | Nature | 2021 | https://conductscience.org/library/papers/34010947 | PubMed |
| 10 | 33630053 | Another front in COVID-19's perfect storm. | Blood | 2021 | https://conductscience.org/library/papers/33630053 | PubMed |
| 11 | 29314720 | Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon. | Immun Inflamm Dis | 2018 | https://conductscience.org/library/papers/29314720 | PubMed |
| 12 | 26905366 | A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis. | Chest | 2016 | https://conductscience.org/library/papers/26905366 | PubMed |
| 13 | 23071157 | Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. | Circ Res | 2013 | https://conductscience.org/library/papers/23071157 | PubMed |
| 14 | 32369280 | Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32369280 | PubMed |
| 15 | 25775976 | The platelet serotonin-release assay. | Am J Hematol | 2015 | https://conductscience.org/library/papers/25775976 | PubMed |
| 16 | 35560046 | Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT. | Blood | 2022 | https://conductscience.org/library/papers/35560046 | PubMed |
| 17 | 24677540 | Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder. | Blood | 2014 | https://conductscience.org/library/papers/24677540 | PubMed |
| 18 | 32849618 | Maturation of the Human Immunoglobulin Heavy Chain Repertoire With Age. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849618 | PubMed |
| 19 | 32597954 | Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. | Blood | 2020 | https://conductscience.org/library/papers/32597954 | PubMed |
| 20 | 35225150 | Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology. | Platelets | 2022 | https://conductscience.org/library/papers/35225150 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42539105 | Charge-driven antiviral responses enhance autoreactivity in severe COVID-19. | Res Sq | 2026 | https://conductscience.org/library/papers/42539105 | PubMed |
| 42361778 | Comparison of Igκ and Igλ binding toward influenza virus hemagglutinin and SARS-CoV-2 Spike protein during primary viral infections in humans, mice, and pigs. | Comp Immunol Microbiol Infect Dis | 2026 | https://conductscience.org/library/papers/42361778 | PubMed |
| 42013023 | Non-PF4/heparin-binding, platelet-activating antibodies in heparin-induced thrombocytopenia. | Blood | 2026 | https://conductscience.org/library/papers/42013023 | PubMed |
| 41746733 | Atypical memory B cell clonal expansion and inflammatory programs associate with platelet-activating antibody development in COVID-19. | JCI Insight | 2026 | https://conductscience.org/library/papers/41746733 | PubMed |
| 41112288 | Post-COVID syndrome patients show reduced anti-Spike antibodies compared to COVID-recovered controls, but enhanced IgG4/IgG1 switch after the third vaccine dose. | Front Immunol | 2025 | https://conductscience.org/library/papers/41112288 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PF4 | 5196 | PubTator's text mining | https://conductscience.org/library/genes/5196 | NCBI Gene |
| SELP | 6403 | PubTator's text mining | https://conductscience.org/library/genes/6403 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39576992
GET https://conductscience.org/api/papers/v1/39576992/authors?page=2